← Leaderboards
Simon Cocklin
Drexel University
$3,133,903
Attributed
$3,133,903
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $569.3K · FY2008–20$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$3,133,903 · 6
By mechanism
R01$1,679,554 · 2
R21$826,569 · 2
R56$552,780 · 1
R03$75,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Drexel University
Same institution · by research overlap
- Glorisa J Canino$24,258,907
- Jennifer Mindy Weil$91,167
- Christine M Finck$4,232,950
- Evan M Forman$9,125,863
- Patrick J Loll$8,716,742
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsReagentInfectionHiv-1DesignBaseVirusViralGlycoproteinsInhibitor/AntagonistAntiviral AgentsPharmaceutical ChemistryMolecularSuccessSurface Plasmon ResonancePropertySmall MoleculeBinding SitesAnti-Hiv AgentsSpecificityProteinsStructureAffinityBiology
Grant awards (9)
Novel anti-HIV compounds targeting the HIV-1 matrix protein$555,143
R01 · FY2020 · AI · contact PI
Novel anti-HIV compounds targeting the HIV-1 matrix protein$555,143
R01 · FY2019 · GM · contact PI
Novel anti-HIV compounds targeting the HIV-1 matrix protein$569,268
R01 · FY2018 · GM · contact PI
Design, optimization and mechanism of action of novel HIV-1 entry inhibitors$552,780
R56 · FY2016 · AI · contact PI
Discovery and optimization of novel diamine derivatives as HIV-1 entry inhibitors$189,661
R21 · FY2014 · AI · contact PI
Discovery and optimization of novel diamine derivatives as HIV-1 entry inhibitors$214,589
R21 · FY2013 · AI · contact PI
High-throughput Computational Docking Screen for Small-molecule Inhibitors of HIV$191,194
R21 · FY2011 · AI · contact PI
High-throughput Computational Docking Screen for Small-molecule Inhibitors of HIV$231,125
R21 · FY2010 · AI · contact PI
Development of a High Throughput FRET-based screening assay for the identificatio$75,000
R03 · FY2008 · AI · contact PI